Stay updated on Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial

Sign up to get notified when there's something new on the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A new revision tag v3.6.5 was added to the record history, replacing the previous v3.6.4, indicating an updated version of the study record. This change updates the record's metadata rather than trial data or outcomes.
    Difference
    0.1%
    Check dated 2026-08-08T20:27:48.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The study record's revision history gains a new entry for v3.6.4 and removes the previous v3.6.3 entry, indicating an update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-07-25T13:16:38.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.3, was added to the record history. The previous revision, v3.6.2, was removed from the list.
    Difference
    0.1%
    Check dated 2026-07-03T22:39:55.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A new revision entry, v3.6.2, was added to the study history and the earlier revision v3.6.0 was removed, updating the historical log displayed on the page.
    Difference
    0.1%
    Check dated 2026-06-26T19:41:39.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The study history page now includes new sections for Contacts/Locations and Study Status, expanding access to site contacts and the current trial status. An added numeric item likely represents a version or count marker associated with the update.
    Difference
    0.4%
    Check dated 2026-06-19T17:45:24.000Z thumbnail image
  8. Check
    69 days ago
    Change Detected
    Summary
    Adds quick access to eligibility (Check who can join) and contact information (Find Contact Information) on the study record page. Updates the revision badge to v3.6.0 and removes the previous v3.5.5 entry.
    Difference
    0.4%
    Check dated 2026-06-12T11:44:01.000Z thumbnail image

Stay in the know with updates to Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page.